| Date Filed | Type | Description |
| 08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2020 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 606,557 options to buy
@ $1.7, valued at
$1M
|
|
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2019 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.|
Txns:
| Acquired 22 shares
@ $0 |
|
| 09/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2019 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.|
Txns:
| Acquired 22 shares
@ $0 |
|
| 04/01/2019 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.|
Txns:
| Acquired 211 shares
@ $0.49, valued at
$103.4 |
|
| 01/02/2019 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.|
Txns:
| Acquired 211 shares
@ $0.3419, valued at
$72.1 |
|
| 11/13/2018 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.6099, valued at
$61k
|
|
| 10/01/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2018 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.|
Txns:
| Acquired 211 shares
@ $3.2, valued at
$675.2 |
|
| 04/03/2018 |
4
| Praill Anthony Scott (CFO) has filed a Form 4 on DelMar Pharmaceuticals, Inc.|
Txns:
| Acquired 211 shares
@ $3.2, valued at
$675.2 |
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/20/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/01/2013 |
3/A
| Form 3 - Initial statement of beneficial ownership of securities [amend] |
| 01/25/2006 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |